NPI registry status
Active
2026 NPPES data Pediatric Hematology & Oncology Physician NPI 1639258486 MD
Verify on CMS → Manisha Bansal, MD
Pediatric Hematology & Oncology Physician in Jacksonville, Florida.
This profile is drawn from the federal National Provider Identifier Registry (CMS NPPES), which lists more than 7 million U.S. healthcare providers - including 2,666 in Pediatric Hematology & Oncology Physician, and covers specialty classification, practice address, and Medicare Part D prescribing data when reported. According to CMS, every field reflects the provider's official federal registration, see our methodology.
Federal data, no proprietary rating.
We show these CMS records as-is - no composite score, no star rating, no editorial opinion layered on top.
Prescribing volume
364
Medicare Part D claims · 126 beneficiaries · Pediatric Hematology & Oncology Physician avg: 88
Generic prescribing
84%
generic claims · 16% brand-name · higher generic rates reduce patient out-of-pocket costs
Industry payments
$601.44
22 payments · CMS Open Payments (Sunshine Act)
Source: CMS Medicare Part D Prescriber Public Use File, 2024
What the federal data shows
Manisha Bansal, MD filed 364 Medicare Part D claims in 2024 as a Pediatric Hematology & Oncology Physician in Jacksonville, Florida, prescribing 84% generic.
- 364
- Part D claims, 2024
- 84%
- generic prescribing
- $601.44
- industry payments (Sunshine Act)
- ≥56th
- pct by Part D claim volume (lower-bound band)
Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) - no proprietary rating or editorial opinion is applied.
Federal trust snapshot
What official records show about Manisha Bansal, MD
Federal records show an active NPI with Medicare Part D prescribing activity — verifiable registry data, not a proprietary rating.
- Verified
NPI registry status
Active listing in the CMS National Provider Identifier Registry (NPI 1639258486), first enumerated 11/03/2006.
Source: CMS NPPES
- Reported
Medicare Part D participation
Filed 364 Medicare Part D prescription claims in the 2023 CMS public use file — indicates active Medicare prescribing participation.
Source: CMS Part D Prescriber PUF
- Reported
Board certification signal
Practices in an ABMS-board-eligible specialty; board certification not confirmed in federal records.
- Reported
Industry payment transparency
$601.44 in reported industry payments (22 transfers) in 2024 under the federal Sunshine Act — disclosed transfers of value, not a quality rating.
Source: CMS Open Payments
- State context
State board disciplinary context
Florida statewide board action statistics are published annually — these figures describe aggregate state activity, not Manisha Bansal, MD's individual license status. Verify directly with the state medical board.
Source: FLDOH annual report 2023
- Not in federal data
Individual sanction lookup
PlainDoctor does not publish per-provider disciplinary determinations. Confirm current license and any individual actions through the state medical board or FSMB verification service.
Source: State medical board / FSMB
This trust snapshot summarizes only what appears in federal CMS/NPPES public records. It is not a composite score, star rating, patient review, or clinical recommendation. PlainDoctor never fabricates reviews or AggregateRating schema.
CMS NPPES provider registry desk
NPI 1639258486 · Pediatric Hematology & Oncology Physician
NPI-10 · ENUM-LEGACY · TAX-NARROW · RX-LIGHT · BOOK-THIN · PHOTO-ENUM
- NPI-10 1639258486
- ENUM-LEGACY 2006
- TAX-NARROW 2,666
- RX-LIGHT 364
- BOOK-THIN 126 in Florida
- PHOTO-ENUM Catherine Bollard · 2006
Manisha Bansal, MD's Medicare Part D volume vs every U.S. prescriber
Total Medicare Part D claims, 2024, across all CMS prescribers nationally
364 ≥ 56th percentile 56% of 1,416,883 prescribers are in lower value bands
Each bar is a band; taller bars hold more prescribers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
The percentile is a conservative 100-claim band: it counts only prescribers in lower claim-volume bands. Medicare Part D claim volume is activity context, not a quality measure or recommendation. See methodology § corpus placement.
Source CMS Medicare Part D Prescriber Public Use File · 2024
◑
Board-eligible specialty (heuristic, not verified)
Manisha Bansal, MD practices in an ABMS-board-eligible specialty but we don't have enough CMS-participation signals to confirm active board-certified status. Consult CertificationMatters.org (the official ABMS public lookup).
What does the federal data show about Manisha Bansal, MD?
Quality data not reportedPrimary specialty
Pediatric Hematology & Oncology Physician
Medicare Part D claims
364 314% vs specialty avg
Specialty distribution in Florida
How Pediatric Hematology & Oncology Physician compares to other specialties among Florida providers
Board certification
Not published by CMS
CMS does not publish a per-provider board-certification field in NPPES. PlainDoctor does not have a reliable per-specialty certification rate to show for Pediatric Hematology & Oncology Physician. Verify directly:
How MIPS and board certification work
The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.
Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).
Practice Address
Provider Details
| NPI | 1639258486 |
|---|---|
| Specialty | Pediatric Hematology & Oncology Physician |
| Credentials | MD |
| Gender | Female |
| NPI Issued | 11/03/2006 |
Industry payments received (2024) - CMS Open Payments transparency data
The federal Physician Payments Sunshine Act (part of the Affordable Care Act) requires drug and medical-device manufacturers + group purchasing organizations to publicly report payments and other transfers of value to physicians and teaching hospitals. The data below covers 2024 for Manisha Bansal, MD. Source: openpaymentsdata.cms.gov.
Total received
$601
Largest payer
JAZZ PHARMACEUTICALS INC.
Most common payment type
Food and Beverage
Industry payments are not necessarily indicators of bias, they include research funding, consulting fees for evidence-based work, royalties for inventions, food at conferences, and similar items. The disclosure exists for transparency. Read our methodology for how we interpret this data.
License & disciplinary context - Florida FLDOH 2023 annual report
Aggregate state board data only, NOT a determination of any individual provider's status. The figures below describe statewide disciplinary activity across all ~75K Florida medical licensees in 2023 - they are NOT specific to Manisha Bansal, MD. To verify Manisha Bansal, MD's current license status, search the FLDOH public license lookup directly, or check the Federation of State Medical Boards (FSMB) verification service.
480
Total board actions, Florida 2023
Across 467 cases
6.40
Actions per 1,000 licensees
Florida statewide rate
monetary fine
Most common action type
138 cases
FLDOH publishes annual disciplinary statistics as part of public-record reporting under each state's Administrative Procedure Act. See the full breakdown by action type and year on the Florida disciplinary trends page. Cross-checked against FSMB U.S. Medical Regulatory Trends.
Brand vs generic prescribing mix · Typical
Manisha Bansal, MD - brand share 16.0%
Pediatric Hematology & Oncology Physician average
16% brand-name claims vs 84% generic, on 364 2024 Medicare Part D claims.
The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.
Medicare Part D Prescribing Data
CMS Medicare Part D prescriber-level data for calendar year 2024.
364
Total Claims
$53K
Total Drug Cost
126
Medicare Beneficiaries
Prescribing Breakdown
- 30-Day Fills
- 779.767
- Total Day Supply
- 23,297
- Brand vs Generic
- 16% brand / 84% generic
- Brand Drug Cost
- $46K
- Generic Drug Cost
- $6K
Patient Demographics
- Average Patient Age
- 74.5 years
- Avg HCC Risk Score
- 1.98
- Gender Split
- 56% female / 44% male
Top Prescribed Drugs (Medicare Part D)
Top drugs by claim count for calendar year 2024. Based on Medicare Part D data only.
What Manisha Bansal, MD prescribes most
Top Medicare Part D drugs by claim count, 2024
- Metoprolol Succinate
Metoprolol Succinate
38 claims
- Atorvastatin Calcium
Atorvastatin Calcium
28 claims
- Isosorbide Mononit…
Isosorbide Mononitrate Er
24 claims
- Amlodipine Besylate
Amlodipine Besylate
22 claims
- Nitroglycerin Patch
Nitroglycerin Patch
21 claims
- Eliquis
Eliquis
17 claims
- Metoprolol Tartrate
Metoprolol Tartrate
17 claims
- Cilostazol 12
Cilostazol
12 claims
| Drug | Claims |
|---|---|
| Metoprolol Succinate | 38 |
| Atorvastatin Calcium | 28 |
| Isosorbide Mononitrate Er Isosorbide Mononitrate | 24 |
| Amlodipine Besylate | 22 |
| Nitroglycerin Patch Nitroglycerin | 21 |
| Eliquis Apixaban | 17 |
| Metoprolol Tartrate | 17 |
| Cilostazol | 12 |
| Furosemide | 12 |
| Isosorbide Dinitrate | 11 |
* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.
More Pediatric Hematology & Oncology Physician in FL →
All providers in Florida →
Compare specialties →
Pediatric Hematology & Oncology Physician Overview
How Manisha Bansal, MD fits within the Pediatric Hematology & Oncology Physician landscape nationally.
2,666
Pediatric Hematology & Oncology Physician Providers in US
52
States with Pediatric Hematology & Oncology Physician
88
Avg Claims per Provider
Manisha Bansal, MD's 364 claims are above the specialty average of 88.
Nationwide Pediatric Hematology & Oncology Physician peers with similar MIPS or enrollment year
Two federal-record peer sets for Bansal, both outside Florida so the neighborhoods are not geographic containment.
Same NPPES enumeration year (2006)
Same-specialty clinicians who entered the NPI registry in the same calendar year, outside this state.
Nearby Pediatric Hematology & Oncology Physician Providers in Florida
Other clinicians with the same primary specialty enrolled in Florida, drawn from the same CMS NPPES roster as Bansal.
One of 126 Pediatric Hematology & Oncology Physician providers enrolled in Florida, 5 are shown here.
Dr. Haneen Abdella
MD
Hollywood, FL
Dr. Chenue Abongwa
M.D
Orlando, FL
Dr. Muaz Alabd Alrazzak
MD
Boca Raton, FL
Dr. Minelys Alicea Marrero
M.D.
Saint Petersburg, FL
Dr. Heather Allewelt
MD
Orlando, FL
Compare Pediatric Hematology & Oncology Physician nationally: see state-by-state distribution →
Frequently Asked Questions
What is Manisha Bansal, MD's specialty? ▼
Manisha Bansal, MD specializes in Pediatric Hematology & Oncology Physician and practices in Jacksonville, Florida. Credentials: MD.
How much does Manisha Bansal, MD prescribe under Medicare Part D? ▼
In 2024, Manisha Bansal, MD wrote 364 Medicare Part D claims totaling $53K in drug costs for 126 beneficiaries.
Where is Manisha Bansal, MD located? ▼
Manisha Bansal, MD is located at 807 CHILDRENS WAY, Jacksonville, FL, 32207. Phone: (904) 390-3600.
What is Manisha Bansal, MD's NPI number? ▼
Manisha Bansal, MD's National Provider Identifier (NPI) is 1639258486, issued on 11/03/2006.
Does Manisha Bansal, MD prescribe more brand-name or generic drugs? ▼
Manisha Bansal, MD's prescribing is 16% brand-name and 84% generic drugs by claim count, with $46K in brand drug costs.
How many Pediatric Hematology & Oncology Physician providers are there in the US? ▼
There are 2,666 Pediatric Hematology & Oncology Physician providers across 52 states in the US. The average Pediatric Hematology & Oncology Physician provider writes 88 Medicare Part D claims per year.
What drugs does Manisha Bansal, MD prescribe most often? ▼
Based on 2024 Medicare Part D data, Manisha Bansal, MD's most frequently prescribed drugs include Metoprolol Succinate, Atorvastatin Calcium, Isosorbide Mononitrate Er. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does Manisha Bansal, MD accept Medicare? ▼
Manisha Bansal, MD appears in CMS Medicare data with 364 Part D claims and 126 Medicare beneficiaries in 2024. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify Manisha Bansal, MD's credentials? ▼
Manisha Bansal, MD's NPI is 1639258486 with credentials MD. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.
Data Sources
View source datasets and methodology notes
- Provider Directory
- CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
- Specialty Classification
- NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
- Prescribing Data
- CMS Medicare Part D Prescriber Public Use File (2024). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
- Limitations
- Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.
See our complete data methodology for details on how we collect and process government data.
Data as of August 2026 (NPPES) / 2024 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).
Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology
Every figure on PlainDoctor is rendered directly from the federal CMS NPPES registry, Medicare Part D, MIPS, and Open Payments records, no number is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of August 2026.